2022 Q1 Form 10-Q Financial Statement

#000143774922011649 Filed on May 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $433.3K $342.5K
YoY Change 26.53% 18.17%
% of Gross Profit
Research & Development $198.5K $37.60K
YoY Change 427.9% -14.34%
% of Gross Profit
Depreciation & Amortization $99.00 $0.00
YoY Change -100.0%
% of Gross Profit
Operating Expenses $198.5K $37.60K
YoY Change 427.9% -14.34%
Operating Profit
YoY Change
Interest Expense $47.99K $58.36K
YoY Change -17.77% -73.52%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$679.3K -$438.4K
YoY Change 54.95% -17.33%
Income Tax
% Of Pretax Income
Net Earnings -$679.3K -$438.4K
YoY Change 54.95% -17.33%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share -$2.665K -$1.967K
COMMON SHARES
Basic Shares Outstanding 254.9M 222.9M
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.561M $5.228M
YoY Change -31.88% 6394.81%
Cash & Equivalents $3.561M $5.228M
Short-Term Investments
Other Short-Term Assets $105.7K $154.8K
YoY Change -31.7% 225.78%
Inventory
Prepaid Expenses $105.7K $154.8K
Receivables
Other Receivables
Total Short-Term Assets $3.667M $5.382M
YoY Change -31.88% 4104.67%
LONG-TERM ASSETS
Property, Plant & Equipment $5.837K
YoY Change
Goodwill $166.0K $166.0K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $69.20K $31.70K
YoY Change 118.3% 785.47%
Total Long-Term Assets $1.210M $1.237M
YoY Change -2.16% -4.04%
TOTAL ASSETS
Total Short-Term Assets $3.667M $5.382M
Total Long-Term Assets $1.210M $1.237M
Total Assets $4.877M $6.619M
YoY Change -26.32% 367.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $401.3K $672.3K
YoY Change -40.3% 20.67%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $23.40K
YoY Change -100.0% 4.6%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $401.3K $695.6K
YoY Change -42.31% 20.05%
LONG-TERM LIABILITIES
Long-Term Debt $1.202M $1.373M
YoY Change -12.42% 5769.05%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.202M $1.373M
YoY Change -12.42% 5769.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $401.3K $695.6K
Total Long-Term Liabilities $1.202M $1.373M
Total Liabilities $1.604M $2.068M
YoY Change -22.47% 243.09%
SHAREHOLDERS EQUITY
Retained Earnings -$14.16M -$7.651M
YoY Change 85.08% 27.01%
Common Stock $51.12K $48.34K
YoY Change 5.76% 19.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.273M $4.551M
YoY Change
Total Liabilities & Shareholders Equity $4.877M $6.619M
YoY Change -26.32% 367.19%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$679.3K -$438.4K
YoY Change 54.95% -17.33%
Depreciation, Depletion And Amortization $99.00 $0.00
YoY Change -100.0%
Cash From Operating Activities -$486.4K -$19.22K
YoY Change 2431.54% -94.08%
INVESTING ACTIVITIES
Capital Expenditures $5.936K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$5.940K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $4.913M
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 $5.225M
YoY Change -100.0% 1405.77%
NET CHANGE
Cash From Operating Activities -$486.4K -$19.22K
Cash From Investing Activities -5.940K
Cash From Financing Activities $0.00 $5.225M
Net Change In Cash -$492.4K $5.205M
YoY Change -109.46% 23195.84%
FREE CASH FLOW
Cash From Operating Activities -$486.4K -$19.22K
Capital Expenditures $5.936K $0.00
Free Cash Flow -$492.4K -$19.22K
YoY Change 2462.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
14733 USD
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
255615791
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
255615791
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
254055581
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
CORETEC GROUP INC.
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
255615791
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001375195
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
254055581
CY2021Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2022Q1 us-gaap Cash
Cash
3560954 USD
CY2021Q4 us-gaap Cash
Cash
4053327 USD
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
105739 USD
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
133491 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
3666693 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
4186818 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5837 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
968947 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
989604 USD
CY2022Q1 us-gaap Goodwill
Goodwill
166000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
166000 USD
CY2022Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
69196 USD
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
16343 USD
CY2022Q1 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
1204143 USD
CY2021Q4 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
1171947 USD
CY2022Q1 us-gaap Assets
Assets
4876673 USD
CY2021Q4 us-gaap Assets
Assets
5358765 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
401342 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
307096 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
401342 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
307096 USD
CY2022Q1 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1202251 USD
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1187518 USD
CY2022Q1 us-gaap Liabilities
Liabilities
1603593 USD
CY2021Q4 us-gaap Liabilities
Liabilities
1494614 USD
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
69 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
69 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
51121 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
50809 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17383221 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17295262 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14161331 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13481989 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3273080 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3864151 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4876673 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5358765 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
198494 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37601 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
433323 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
342458 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
47990 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
58362 USD
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
679807 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
438421 USD
CY2022Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
465 USD
CY2021Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-679342 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-438421 USD
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20657 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20057 USD
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
21526 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
222856458
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3864151 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
70973 USD
CY2022Q1 crtg Stock Issued During Period Value Issued For Liabilities
StockIssuedDuringPeriodValueIssuedForLiabilities
17298 USD
CY2022Q1 crtg Stock Issued During Period Value Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodValueStockOptionsExchangedForCommonShares
0 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-679342 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3273080 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
70973 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
18723 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-27752 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-25158 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.003
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.002
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
254932103
CY2021Q1 crtg Stock Issued During Period Value Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodValueStockOptionsExchangedForCommonShares
0 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4913200 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
62785 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
18723 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-438421 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
4550733 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-679342 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
736957 USD
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
50000 USD
CY2021Q1 crtg Stock Issued During Period Value Issued For Liabilities
StockIssuedDuringPeriodValueIssuedForLiabilities
70264 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-438421 USD
CY2022Q1 us-gaap Depreciation
Depreciation
99 USD
CY2021Q1 us-gaap Depreciation
Depreciation
0 USD
CY2022Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
52853 USD
CY2021Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
12750 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
111545 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
346492 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-486436 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19215 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5936 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 USD
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 USD
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
23181 USD
CY2022Q1 crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
0 USD
CY2021Q1 crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
334651 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4913200 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5224670 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-492372 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5205455 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4053327 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22219 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3560954 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5227674 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
33298 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
33603 USD
CY2022Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2021Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
50000 USD
CY2022Q1 crtg Stock Options Exchanged For Common Stock
StockOptionsExchangedForCommonStock
180 USD
CY2021Q1 crtg Stock Options Exchanged For Common Stock
StockOptionsExchangedForCommonStock
240 USD
CY2022Q1 crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
17298 USD
CY2021Q1 crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
70264 USD
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
235716997
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
208651539
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2022Q1 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1202251 USD
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1187518 USD
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
142604000
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0515
CY2022Q1 crtg Class Of Warrant Or Right Contractual Term
ClassOfWarrantOrRightContractualTerm
P4Y4M20D
CY2022Q1 crtg Class Of Warrant Or Right Intrinsic Value
ClassOfWarrantOrRightIntrinsicValue
2405050 USD
CY2020Q2 crtg Share Exchange Agreement Number Of Options Authorized
ShareExchangeAgreementNumberOfOptionsAuthorized
21500000
CY2020Q2 crtg Share Exchange Agreement Exchange Ratio
ShareExchangeAgreementExchangeRatio
0.6 pure
CY2022Q1 crtg Share Based Compensation Arrangement By Share Based Payment Award Options Exchanged
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExchanged
1500000
CY2022Q1 crtg Stock Issued During Period Shares Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares
900000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
950000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.055
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
950000
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.055
CY2022Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
53161609
CY2022Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P3Y11M23D
CY2022Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
52911609
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
4707 USD
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
3780 USD

Files In Submission

Name View Source Status
0001437749-22-011649-index-headers.html Edgar Link pending
0001437749-22-011649-index.html Edgar Link pending
0001437749-22-011649.txt Edgar Link pending
0001437749-22-011649-xbrl.zip Edgar Link pending
crtg-20220331.xsd Edgar Link pending
crtg-20220331_cal.xml Edgar Link unprocessable
crtg-20220331_def.xml Edgar Link unprocessable
crtg-20220331_lab.xml Edgar Link unprocessable
crtg-20220331_pre.xml Edgar Link unprocessable
crtg20220331_10q.htm Edgar Link pending
crtg20220331_10q_htm.xml Edgar Link completed
ex_372163.htm Edgar Link pending
ex_372164.htm Edgar Link pending
ex_372165.htm Edgar Link pending
ex_372166.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending